Relapse rate and associated-factor of recurrence after stopping NUCs therapy with different prolonged consolidation therapy in HBeAg positive CHB patients.

Relapse rate and associated-factor of recurrence after stopping NUCs therapy with different prolonged consolidation therapy in HBeAg positive CHB patients.

BACKGROUND: Many chronic hepatitis B (CHB) patients recur after off-therapy and have to accept prolonged consolidation therapy with NUCs. We investigated the rate of HBV relapse after stopping NUCs therapy with different time period of prolonged consolidation therapy in HBeAg positive CHB patients,...

Full description

Bibliographic Details
Main Authors: Xingfei Pan, Ka Zhang, Xiaoan Yang, Jiayi Liang, Haixia Sun, Xuejun Li, Yong Zou, Qingqiang Xu, Geng An, Gang Li, Qihuan Xu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3701059?pdf=render

Internet

http://europepmc.org/articles/PMC3701059?pdf=render

Similar Items